Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
REGN-5381 by Regeneron Pharmaceuticals for Hypertension: Likelihood of Approval
REGN-5381 is under clinical development by Regeneron Pharmaceuticals and currently in Phase I for Hypertension. According to GlobalData, Phase I...
Data Insights
REGN-5381 by Regeneron Pharmaceuticals for Congestive Heart Failure (Heart Failure): Likelihood of Approval
REGN-5381 is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Congestive Heart Failure (Heart Failure). According...